Effect of a β2-Adrenoceptor Stimulation on Hyperglycemia-Induced Endothelial Dysfunction

Journal of Pharmacology and Experimental Therapeutics

Volumn 308, Issue 2, 2004, Pages 564-573

  Kabat, Armin ^b   Pönicke, Klaus ^b   Salameh, Aida ^a   Mohr, Friedrich Wilhelm ^a   Dhein, Stefan ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYANOPINDOLOL I 125; GLUCOSE; METOPROLOL; NITRIC OXIDE; NUCLEOTIDE; RADIOLIGAND; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SALBUTAMOL;

ADRENERGIC STIMULATION; ANIMAL; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; ENZYMOLOGY; GIANT CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; METABOLISM; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SWINE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ADRENERGIC BETA-AGONISTS; ANIMALS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GIANT CELLS; HYPERGLYCEMIA; NADPH DEHYDROGENASE; NITRIC OXIDE; NUCLEOTIDES; RECEPTORS, ADRENERGIC, BETA-2; SWINE; VASCULAR DISEASES;

EID: 1642457238     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.057554     Document Type: Article

References (52)

1. 2 in high glucose medium. Diabetes 44:520-526.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Brodde O-E, Vogelsang M, Broede A, Michel-Reher M, Beisenbusch-Schafer E, Hakim K, and Zerkowski HR (1998) Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 31:585-594.
4. Brodde O-E and Michel MC (1999) Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51:651-689.
5. Cagliero E, Roth T, Roy S, and Lorenzi M (1991) Characteristics and mechanisms of high-glucose-induced over-expression of basement membrane components in cultured human endothelial cells. Diabetes 49:102-110.
6. Cameron NE and Cotter MA (1992) Impaired contraction and relaxation in aorta from stroptozotocin-diabetic rats: role of polyol pathway. Diabetologia 35:10011-10019.
7. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
8. Dhein S, Röhnert P, Markau S, Kotchi-Kotchi E, Becker K, Poller U, Osten B, and Brodde O-E (2000) Cardiac beta-adrenoceptors in chronic uremia: studies in humans and rats. J Am Coll Cardiol 36:608-617.
9. 2-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 346:27-31.
10. Dhein S, Kabat A, Olbrich A, Rösen P, Schröder H, and Mohr F-W (2003) Effect of chronic treatment with vitamin E on endothelial dysfunction in a type I in-vivo diabetes mellitus model and in vitro. J Pharmacol Exp Ther 305:114-122.
11. Donnelly R, Enslie-Smith AM, Gardner ID, and Morris AD (2000) ABC of arterial and venous disease: vascular complications of diabetes. BMJ 320:1062-1066.
12. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, and Brownlee M (2000) Hypergylcemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97:12222-12226.
13. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, and Brownlee M (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Investig 108:1341-1348.
14. Feelisch M and Noack EA (1987) Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 139:19-30.
15. Felaco M, Grilli A, De Lutiis MA, Patruno A, Libertini N, Taccardi AA, Di Napoli P, Di Guilio C, Barbacane R, and Conti P (2001) Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts. Ann Clin Lab Sci 31:179-186.
16. 2-adrenoceptors in human umbilical vein endothelium in vitro. Br J Pharmacol 126:1872-1880.
17. Fortes ZB, Garcia Leme J, and Scivoletto R (1983) Influence of diabetes on the reactivity in mesenteric microvessels to histamine, bradykinin and acetylcholine. Br J Pharmacol 78:39-48.
18. George ST, Ruoho AE, and Malbon CC (1986) N-Glycosylation in expression and function of beta-adrenergic receptors. J Biol Chem 261:16559-16564.
19. Hein KD and King GL (1996) Vascular abnormalities in diabetes mellitus, in Contemporary Endocrinology: Endocrinology of the Vasculature (Sowers JR ed) pp 135-143, Humana Press Inc., Totowa, NJ.
20. Hempel A, Maasch C, Heintze U, Lindschau C, Dietz R, Luft FC, and Haller H (1997) High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res 81:363-371.
21. Hope BT, Michael GJ, Knigge KM, and Vincent SR (1991) Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 88:2811-2814.
22. 2+ influx into the endothelium contributes to the decrease in endothelium-dependent relaxation in the aorta of streptozotozin-induced diabetic mice. Res Com Mol Pathol Pharmacol 90:69-74.
23. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 37:264-269.
24. Kelm M, Dahmann R, Wink D, and Feelisch M (1997) (1997) The nitric oxide/superoxide assay. J Biol Chem 272:9922-9932.
25. Korshunov SS, Skulachev VP, and Starkov AA (1997) High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416:15-18.
26. Kwong LK and Sohal RS (1998) Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch Biochem Biophys 350:118-126.
27. Magill SB and Dananberg J (1996) Effects of hyperglycemia on vascular endothelium nitric oxide metabolism, in Contemporary Endocrinology: Endocrinology of the Vasculature (Sowers JR ed) pp. 145-156, Humana Press Inc., Totowa, NJ.
28. Mancusi G, Hutter C, Baumgartner-Parzer S, Schmidt K, Schütz W, and Sexl V (1996) High-glucose incubation of human umbilical-vein endothelial cells does not alter expression and function either of G-protein alpha-subunits or of endothelial NO synthase. Biochem J 315:281-287.
29. Michell BJ, Chen Z, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, and Kemp BE (2001) Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276:17625-17628.
30. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, Dohi K, Makita Z, Vlassara H, and Bucala R (1993) Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 143:1649-1656.
31. Nishikawa T, Edelstein D, Du XL, Yamagishi S-I, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes H-P, Giardino I, and Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (Lond) 404:787-790.
32. 2-adrenoceptors in intact human lymphocytes. Arch Int Pharmacodyn 272:24-39.
33. Olbrich A, Rösen P, Hilgers R-D, and Dhein S (1996) Fosinopril improves regulation of vascular tone in mesenteric bed of diabetic rats. J Cardiovasc Pharmacol 27:187-194.
34. Olbrich A, Salameh A, Roesen P, and Dhein S (1999) Different effects of the β-adrenoceptor antagonists celiprolol and metoprolol on vascular structure and function in long-term type I diabetic rats. J Cardiovasc Pharmacol 33:193-203.
35. Pieper GM and Peltier BA (1995) Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cardiovasc Pharmacol 25:397-403.
36. Pieper GM, Langenstroer P, and Siebeneieh W (1997) Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 34:145-156.
37. Rösen P, Ballhausen T, Bloch W, and Addicks K (1995) Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 38:1157-1168.
38. Rosenthal AM and Gotlieb AI (1990) Macrovascular endothelial cells from porcine aorta, in Cell Culture Techniques in Heart and Vessel Research (Piper HM ed) pp 117-129, Springer, Berlin.
39. Sank A, Wie D, Reid J, Ertl D, Nimni M, Weaver F, Yellin A, and Tuan TL (1991) Human endothelial cells are defective in diabetic vascular disease. J Surg Res 57:647-653.
40. Salameh A and Dhein S (1998) Influence of chronic exposure to high concentrations of D-glucose and long-term b-blocker treatment on intracellular calcium concentrations of porcine aortic endothelial cells. Diabetes 47:407-413.
41. Salameh A, Zinn M, and Dhein S (1997) High D-glucose induces alterations of endothelial cell structure in a cell-culture model. J Cardiovasc Pharmacol 30:182-190.
42. Seyfarth T, Gerbershagen HP, Giessler C, Leineweber K, Heinroth-Hoffmann I, Pönicke K, and Brodde OE (2000) The cardiac β -adrenoceptor-G-protein(s)-adenyl cyclase system in monocrotaline-treated rats. J Mol Cell Cardiol 32:2315-2326.
43. Soriano FG, Virag L, and Szabo C (2001) Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J Mol Med 79:437-448.
44. Stiles GL (1985) Deglycosylated mammalian beta 2-adrenergic receptors: effect on radioligand binding and peptide mapping. Arch Biochem Biophys 237:65-71.
45. Stockklauser-Farber K, Ballhausen T, Laufer A, and Rösen P (2000) Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim Biophys Acta 1535:10-20.
46. Tesfamarian B (1994) Free radicals in diabetic endothelial cell dysfunction. Free Radical Biol Med 16:383-391.
47. Tesfamariam B, Palacino JJ, Weisbrod RM, and Cohen RA (1993) Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol 21:205-211.
48. Voyta JC, Via DP, Butterfield CE, and Zetter BR (1984) Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 99:2034-2040.
49. Wu G and Meininger CJ (1995) Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat. Am J Physiol 269:H1312-H1318.
50. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, Arnot D, and Uyeda K (2001) A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 98:9116-9121.
51. Xia P, Inoguchi T, Kern TS, Engerman RI, Oates PJ, and King GL (1994) Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43:1122-1129.
52. Zink S, Rösen P, Sackmann B, and Lemoine H (1993) Regulation of endothelial permeability by beta-adrenoceptor agonists: contribution of beta1- and beta2-adrenoceptors. Biochim Biophys Acta 1178:286-298.